WS #16589
In contrast to the broader market turmoil, healthcare stocks are demonstrating significant defensive strength. AbbVie reported a massive earnings beat with a 100% YoY EPS increase and raised its full-year guidance, supported by strong Skyrizi and Rinvoq sales. Sanofi also lifted its 2026 growth targets following strong Dupixent performance. These results highlight the sector's resilience and attractiveness as a safe haven during periods of macroeconomic and geopolitical instability.
Healthcare Defensive Strength
In contrast to the broader market turmoil, healthcare stocks are demonstrating significant defensive strength. AbbVie reported a massive earnings beat with a 100% YoY EPS increase and raised its full-year guidance, supported by strong Skyrizi and Rinvoq sales. Sanofi also lifted its 2026 growth targets following strong Dupixent performance. These results highlight the sector's resilience and attractiveness as a safe haven during periods of macroeconomic and geopolitical instability.